department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Tolmar Pharmaceuticals Inc · pharmadog

PUBLIC COMPANY

Tolmar Pharmaceuticals Inc

updated 2mo ago

community read0 votes

pipeline

4

marketed

3

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(4)

pipeline depth4 products

3Marketed1Unknown

(betamethasone dipropionate + calcipotriene)

Plaque Psoriasis (Psoriasis Vulgaris)

Central Precocious Puberty

leuprolide acetate ER

Metastatic Prostate Cancer

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Tolmar Pharmaceuticals Inc jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

mentioned in

0news items

entity-linker matched

Data sources

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Active trials

phase3Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Canceractive not recruitingn=250
phase3Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Studyenrolling by invitationn=250
phase4A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Monthsactive not recruitingn=110

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?